Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

MYM Nutraceuticals Inc MYMMF

Healthcare Drug Manufacturers - Major
MYM Nutraceuticals Inc is a Canada based company engaged in the business of acquiring and developing natural remedies. The company is focused on the medical marijuana business by producing cannabis growing facilities and products.


GREY:MYMMF - Post by User

MYM Nutraceuticals Inc
Bullboard Posts
User Avatar Image
(3)
•••
Comment by WeeblesWobbleon Mar 08, 2019 12:54pm
58 Views
Post# 29462039

RE:RE:RE:NEWS with CROP

RE:RE:RE:NEWS with CROPI would love to know what variables and pricing were used to come up with the $26 million gross figure. We know there are 120 acres but we don't know:

what plant spacing will be (which determines number of plants per acre);
what CBD yield per plant will be;
what CBD pricing model was used.

That said, even if the $26 million number is wildly optimistic (just short of misleading), investing $500K to get 50% of $6.5 million of gross revenue (believing actual yield/pricing would be only 25% of the $26 million) would not be a bad ROI (return of 6.5 times $500K invested).

IMO, best thing about this deal is that MYM gets a revenue stream which could become a lucrative annual addition to the bottom line.
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities